Medications


Clinical Practice Guidelines
http://www.state.sc.us/dmh/clinical/guidelines.htm
Refer to this site for medication guidelines from various organizations and for many diagnostic conditions.   

Drug Interactions
http://drug-interactions.com
This useful site presents, in table form, Clinically Used Drugs Metabolized by Cytochrome P450

Harvard Psychopharmacology Algorithm Project
http://www.mhc.com/Algorithms/index.html
The main aim of this project is to improve the quality of psychopharmacological thinking and care by promoting evidence-based practice especially through the use of computerized algorithms.  The evidence considered includes high quality empirical research studies but also uncontrolled studies and compilations of expert opinion and practice guidelines.  The Project's algorithms provide a base of knowledge for determination of what is best for a particular patient.  They are not a set of steps to memorize and use without deviation.I

MAOI Diet
http://www.dr-bob.org/tips/maoi.html
This useful site includes information about the special dietary precautions for patients on MAOI medications for depression.

Prescription Drug Patient Assistance Programs:
http://www.nami.org/helpline/freemed.htm  (NAMI)
http://www.themedicineprogram.com/
These sites all offer help in obtaining medications without charge or with reduced charges.  Most are through the pharmaceutical companies' indigent programs. 

Psychopharmacology Tips
http://www.dr-bob.org/tips
This is one of the best sites for information about medications. Much of it is opinions of various "experts," some of whom have conflicts of interest (that is, are paid by pharmaceutical companies). Many of the tips are based on anecdotal impressions rather than controlled research. However, Dr. Hsiung, who oversees this site, appears to be honest and truly interested in quality.

Schizophrenia Treatment ("PORT")
http://www.state.sc.us/dmh/clinical/port.htm
This important article, from Schizophrenia Bulletin, contains a very specific and comprehensive set of treatment guidelines for schizophrenia (referred to as "PORT" recommendations from the "Patient Outcomes Research Team" funded by NIMH). Eighteen of the recommendations address antipsychotic agents and adjunctive pharmacotherapies; the remaining 12 address electroconvulsive therapy, psychological interventions, family interventions, vocational rehabilitation, and assertive community treatment/intensive case management.